Funding will Advance Cellino’s Advanced Biomanufacturing Technology for Personalized Regenerative Medicines CAMBRIDGE, Mass. – Cellino Biotech, Inc. today announced that the Advanced Research Projects Agency for Health (ARPA-H), an agency within the U.S. Department of Health and Human Services, has awarded it up to $25 million in funding to develop an ultra-scalable, autonomous, cassette-based advanced biomanufacturing technology for personalized regenerative medicines. Cellino’s NEBULA (NExt-generation Biomanufacturing ULtra-scalable … Continue reading Cellino Awarded $25M in Funding from the Advanced Research Projects Agency for Health (ARPA-H)

Succeeds Dr. Stephen Schwartz Following 14-Year Tenure BURLINGTON, Mass., Sept. 4, 2024 /PRNewswire/ — Azenta, Inc. (Nasdaq: AZTA) (“Azenta” or “the Company”), today announced that John P. Marotta will join the Company as President and CEO effective September 9, 2024, succeeding Dr. Stephen Schwartz, who is retiring following a distinguished tenure. Dr. Schwartz will remain as an advisor to Azenta to ensure a smooth and successful transition.  Mr. Marotta has two decades … Continue reading AZENTA ANNOUNCES APPOINTMENT OF JOHN P. MAROTTA AS CEO